Ameritas Investment Partners’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-25,068
Closed -$17.7K 3298
2025
Q1
$17.7K Hold
25,068
﹤0.01% 2606
2024
Q4
$20.2K Hold
25,068
﹤0.01% 2637
2024
Q3
$24.9K Hold
25,068
﹤0.01% 2550
2024
Q2
$38.9K Buy
+25,068
New +$39.1K ﹤0.01% 2278
2023
Q2
Sell
-14,478
Closed -$12.4K 3178
2023
Q1
$12.4K Hold
14,478
﹤0.01% 2649
2022
Q4
$18K Hold
14,478
﹤0.01% 2606
2022
Q3
$25K Hold
14,478
﹤0.01% 2411
2022
Q2
$32K Hold
14,478
﹤0.01% 2278
2022
Q1
$48K Hold
14,478
﹤0.01% 2081
2021
Q4
$66K Hold
14,478
﹤0.01% 1959
2021
Q3
$104K Hold
14,478
﹤0.01% 1667
2021
Q2
$116K Buy
+14,478
New +$122K ﹤0.01% 1630

Other funds holding OCGN

Ameritas Investment Partners's OCGN Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Ocugen (OCGN) in Q2 2025, closing a stake of 25,068 shares — an estimated $17.7K sold.

Ameritas Investment Partners first reported a position in OCGN in Q2 2021 and held it in 12 quarters. The position peaked at $116K in Q2 2021. 104 funds tracked by Wall St. Rank hold OCGN as of Q2 2025.

  • Ameritas Investment Partners reported no remaining Ocugen position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 25,068 Ocugen shares in Q2 2025, an estimated $17.7K.
  • Ameritas Investment Partners first reported a position in Ocugen in Q2 2021 and held it in 12 quarters.
  • Ameritas Investment Partners's Ocugen position peaked at $116K in Q2 2021.
  • 104 funds tracked by Wall St. Rank held Ocugen as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.